Characterization of the gastrointestinal microbiota in health and inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 18, Issue 2, 2012, Pages 372-390

  De Cruz, Peter ^a,b   Prideaux, Lani ^a,b   Wagner, Josef ^c   Ng, Siew C ^d,e   McSweeney, Chris ^f   Kirkwood, Carl ^c   Morrison, Mark ^f   Kamm, Michael A ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^f CSIRO   (Australia)

Author keywords

enteric bacterial flora; inflammatory bowel disease; metagenomic, microbiota

Indexed keywords

CROHN DISEASE; ENTERITIS; ILEITIS; INTESTINE FLORA; METAGENOMICS; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

ANIMALS; BACTERIA; DIET; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATORY BOWEL DISEASES; METABOLOME; METAGENOME; METAGENOMICS; MICE; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; PHYLOGENY; PROTEOMICS; RATS; TRANSCRIPTOME; ZEBRAFISH;

EID: 84855717029     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21751     Document Type: Review

References (323)

1. Ley RE, Peterson DA, Gordon JI,. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell. 2006; 124: 837-848. (Pubitemid 43261456)
2. Savage DC,. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol. 1977; 31: 107-133.
3. Frank DN, St Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007; 104: 13780-13785. (Pubitemid 350003397)
4. Suau A, Bonnet R, Sutren M, et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol. 1999; 65: 4799-4807.
5. Strober W, Fuss IJ, Blumberg RS,. The immunology of mucosal models of inflammation. Annu Rev Immunol. 2002; 20: 495-549. (Pubitemid 34293433)
6. Sellon RK, Tonkonogy S, Schultz M, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 1998; 66: 5224-5231. (Pubitemid 29044613)
7. Sartor RB,. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology. 2004; 126: 1620-1633. (Pubitemid 38649878)
8. Shen B, Achkar JP, Lashner BA, et al. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis. 2001; 7: 301-305. (Pubitemid 33062095)
9. Gionchetti P, Rizzello F, Venturi A, et al. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Pharmacol Ther. 1999; 13: 713-718. (Pubitemid 29276839)
10. Ohkusa T, Kato K, Terao S, et al. Newly developed antibiotic combination therapy for ulcerative colitis: a double-blind placebo-controlled multicenter trial. Am J Gastroenterol. 2010; 105: 1820-1829.
11. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000; 119: 305-309. (Pubitemid 30621980)
12. Kruis W, Fric P, Pokrotnieks J, et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut. 2004; 53: 1617-1623. (Pubitemid 39434105)
13. Rutgeerts P, Goboes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet. 1991; 338: 771-774.
14. Lee E,. Split ileostomy in the treatment of Crohn's disease of the colon. Ann R Coll Surg Engl. 1975; 56: 94-102.
15. D'Haens GR, Geboes K, Peeters M, et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology. 1998; 114: 262-267. (Pubitemid 28093532)
16. Overstreet AMC, Ramer-Tait AE, Atherly TA, et al. W1829 changes in composition of the intestinal microbiota precede onset of colitis in genetically-susceptible (IL-10-/-) mice. Gastroenterology. 2010; 138:748-749.
17. Sokol H, Seksik P,. The intestinal microbiota in inflammatory bowel diseases: time to connect with the host. Curr Opin Gastroenterol. 2010; 26: 327-331.
18. Ley RE, Lozupone CA, Hamady M, et al. Worlds within worlds: evolution of the vertebrate gut microbiota. Nat Rev Microbiol. 2008; 6: 776-788.
19. Peterson DA, Frank DN, Pace NR, et al. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe. 2008; 3: 417-427. (Pubitemid 351773097)
20. Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006; 312: 1355-1359. (Pubitemid 43839542)
21. Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project. Nature. 2007; 449: 804-810. (Pubitemid 47598620)
22. Zoetendal EG, Akkermans AD, De Vos WM,. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol. 1998; 64: 3854-3859. (Pubitemid 28462983)
23. Tannock GW,. The search for disease-associated compositional shifts in bowel bacterial communities of humans. Trends Microbiol. 2008; 16: 488-495.
24. Tannock GW,. Molecular assessment of intestinal microflora. Am J Clin Nutr. 2001; 73 (Suppl): 410S-414S. (Pubitemid 32113264)
25. Zoetendal EG, von Wright A, Vilpponen-Salmela T, et al. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol. 2002; 68: 3401-3407. (Pubitemid 34734038)
26. Muyzer G, Smalla K,. Application of denaturing gradient gel electrophoresis (DGGE) and temperature gradient gel electrophoresis (TGGE) in microbial ecology. Antonie Van Leeuwenhoek. 1998; 73: 127-141. (Pubitemid 28209906)
27. Tannock GW,. The intestinal microflora: potentially fertile ground for microbial physiologists. Adv Microb Physiol. 2000; 42: 25-46. (Pubitemid 30465951)
28. Seksik P, Rigottier-Gois L, Gramet G, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut. 2003; 52: 237-242. (Pubitemid 36115065)
29. Franks AH, Harmsen HJ, Raangs GC, et al. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol. 1998; 64: 3336-3345. (Pubitemid 28411456)
30. Leser TD, Lindecrona RH, Jensen TK, et al. Changes in bacterial community structure in the colon of pigs fed different experimental diets and after infection with Brachyspira hyodysenteriae. Appl Environ Microbiol. 2000; 66: 3290-3296. (Pubitemid 30624570)
31. Kaplan CW, Astaire JC, Sanders ME, et al. 16S ribosomal DNA terminal restriction fragment pattern analysis of bacterial communities in feces of rats fed Lactobacillus acidophilus NCFM. Appl Environ Microbiol. 2001; 67: 1935-1939. (Pubitemid 33644968)
32. Nagashima K, Hisada T, Sato M, et al. Application of new primer-enzyme combinations to terminal restriction fragment length polymorphism profiling of bacterial populations in human feces. Appl Environ Microbiol. 2003; 69: 1251-1262. (Pubitemid 36204859)
33. Zoetendal EG, Collier CT, Koike S, et al. Molecular ecological analysis of the gastrointestinal microbiota: a review. J Nutr. 2004; 134: 465-472. (Pubitemid 38141834)
34. Andersson AF, Lindberg M, Jakobsson H, et al. Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS ONE. 2008; 3: e2836.
35. Sanger F, Nicklen S, Coulson AR,. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74: 5463-5467.
36. Ahmadian A, Ehn M, Hober S,. Pyrosequencing: history, biochemistry and future. Clin Chim Acta. 2006; 363: 83-94. (Pubitemid 41748205)
37. El Fantroussi S, Urakawa H, Bernhard AE, et al. Direct profiling of environmental microbial populations by thermal dissociation analysis of native rRNAs hybridized to oligonucleotide microarrays. Appl Environ Microbiol. 2003; 69: 2377-2382. (Pubitemid 36443661)
38. Wang AM, Doyle MV, Mark DF,. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci U S A. 1989; 86: 9717-9721. (Pubitemid 20030704)
39. Schloss PD, Handelsman J,. Introducing DOTUR, a computer program for defining operational taxonomic units and estimating species richness. Appl Environ Microbiol. 2005; 71: 1501-1506. (Pubitemid 40396689)
40. Mackie RI, Sghir A, Gaskins HR,. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr. 1999; 69: 1035S-1045S. (Pubitemid 29205082)
41. Hong PY, Lee BW, Aw M, et al. Comparative analysis of fecal microbiota in infants with and without eczema. PLoS One. 2010; 5: e9964.
42. Cucchiara S, Iebba V, Conte MP, et al. The microbiota in inflammatory bowel disease in different age groups. Dig Dis. 2009; 27: 252-258.
43. Koenig JE, Spor A, Scalfone N, et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A. 2011; 108: 4578-4585.
44. Savino F, Roana J, Mandras N, et al. Faecal microbiota in breast-fed infants after antibiotic therapy. Acta Paediatr. 2011; 100: 75-78.
45. Hviid A, Svanstrom H, Frisch M,. Antibiotic use and inflammatory bowel diseases in childhood. Gut. 2011; 60: 49-54.
46. Penders J, Thijs C, Vink C, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics. 2006; 118: 511-521. (Pubitemid 46085405)
47. Fallani M, Young D, Scott J, et al. Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J Pediatr Gastroenterol Nutr. 2010; 51: 77-84.
48. Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S. A; 107: 11971-11975.
49. Gronlund MM, Lehtonen OP, Eerola E, et al. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr. 1999; 28: 19-25. (Pubitemid 29292870)
50. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr. 2000; 30: 61-67. (Pubitemid 30349947)
51. Favier CF, Vaughan EE, De Vos WM, et al. Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol. 2002; 68: 219-226. (Pubitemid 34031183)
52. Hopkins MJ, Macfarlane GT, Furrie E, et al. Characterisation of intestinal bacteria in infant stools using real-time PCR and northern hybridisation analyses. FEMS Microbiol Ecol. 2005; 54: 77-85. (Pubitemid 41138022)
53. Penders J, Vink C, Driessen C, et al. Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR. FEMS Microbiol Lett. 2005; 243: 141-147. (Pubitemid 40164400)
54. Benno Y, Sawada K, Mitsuoka T,. The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiol Immunol. 1984; 28: 975-986. (Pubitemid 14012186)
55. Lundequist B, Nord CE, Winberg J,. The composition of the faecal microflora in breastfed and bottle fed infants from birth to eight weeks. Acta Paediatr Scand. 1985; 74: 45-51. (Pubitemid 15174105)
56. Stark PL, Lee A,. The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. J Med Microbiol. 1982; 15: 189-203. (Pubitemid 12100569)
57. Dore J, Sghir A, Hannequart-Gramet G, et al. Design and evaluation of a 16S rRNA-targeted oligonucleotide probe for specific detection and quantitation of human faecal Bacteroides populations. Syst Appl Microbiol. 1998; 21: 65-71. (Pubitemid 28172092)
58. Adlerberth I, Carlsson B, de Man P, et al. Intestinal colonization with Enterobacteriaceae in Pakistani and Swedish hospital-delivered infants. Acta Paediatr Scand. 1991; 80: 602-610.
59. Martin R, Heilig GH, Zoetendal EG, et al. Diversity of the Lactobacillus group in breast milk and vagina of healthy women and potential role in the colonization of the infant gut. J Appl Microbiol. 2007; 103: 2638-2644. (Pubitemid 350191191)
60. Martin R, Jimenez E, Heilig H, et al. Isolation of bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-time PCR. Appl Environ Microbiol. 2009; 75: 965-969.
61. Collado MC, Isolauri E, Laitinen K, et al. Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. Am J Clin Nutr. 2010; 92: 1023-1030.
62. Wang M, Karlsson C, Olsson C, et al. Reduced diversity in the early fecal microbiota of infants with atopic eczema. J Allergy Clin Immunol. 2008; 121: 129-134.
63. Penders J, Thijs C, van den Brandt PA, et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut. 2007; 56: 661-667. (Pubitemid 46662932)
64. Kirjavainen PV, Arvola T, Salminen SJ, et al. Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut. 2002; 51: 51-55. (Pubitemid 34717743)
65. Gore C, Munro K, Lay C, et al. Bifidobacterium pseudocatenulatum is associated with atopic eczema: a nested case-control study investigating the fecal microbiota of infants. J Allergy Clin Immunol. 2008; 121: 135-140.
66. Forno E, Onderdonk AB, McCracken J, et al. Diversity of the gut microbiota and eczema in early life. Clin Mol Allergy. 2008; 6: 11.
67. Murray CS, Tannock GW, Simon MA, et al. Fecal microbiota in sensitized wheezy and non-sensitized non-wheezy children: a nested case-control study. Clin Exp Allergy. 2005; 35: 741-745. (Pubitemid 40961346)
68. Kalliomaki M, Isolauri E,. Role of intestinal flora in the development of allergy. Curr Opin Allergy Clin Immunol. 2003; 3: 15-20. (Pubitemid 36159343)
69. Devereux G,. The increase in the prevalence of asthma and allergy: food for thought. Nat Rev Immunol. 2006; 6: 869-874. (Pubitemid 44631655)
70. Wang Y, McCusker C,. Neonatal exposure with LPS and/or allergen prevents experimental allergic airways disease: development of tolerance using environmental antigens. J Allergy Clin Immunol. 2006; 118: 143-151. (Pubitemid 43946471)
71. Probert CS, Brown M,. Are there any ethnic groups that are more likely to develop IBD? Inflamm Bowel Dis. 2008; 14 (suppl 2): S24-25.
72. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science. 2005; 308: 1635-1638. (Pubitemid 40807514)
73. Biagi E, Nylund L, Candela M, et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One. 2010; 5: e10667.
74. Durban A, Abellan JJ, Jimenez-Hernandez N, et al. Assessing gut microbial diversity from feces and rectal mucosa. Microb Ecol. 2011; 61: 123-133.
75. Vanhoutte T, Huys G, Brandt E, et al. Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers. FEMS Microbiol Ecol. 2004; 48: 437-446. (Pubitemid 38648930)
76. Maukonen J, Satokari R, Matto J, et al. Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria. J Med Microbiol. 2006; 55: 625-633.
77. Booijink CC, El-Aidy S, Rajilic-Stojanovic M, et al. High temporal and inter-individual variation detected in the human ileal microbiota. Environ Microbiol. 2010; 12: 3213-3217.
78. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature. 2009; 457: 480-484.
79. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010; 464: 59-65.
80. Tap J, Mondot S, Levenez F, et al. Towards the human intestinal microbiota phylogenetic core. Environ Microbiol. 2009; 11: 2574-2584.
81. Turnbaugh PJ, Quince C, Faith JJ, et al. Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins. Proc Natl Acad Sci U S A. 2010; 107: 7503-7508.
82. Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006; 55: 205-211. (Pubitemid 43117279)
83. Li M, Wang B, Zhang M, et al. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A. 2008; 105: 2117-2122. (Pubitemid 351439474)
84. Sekelja M, Berget I, Naes T, et al. Unveiling an abundant core microbiota in the human adult colon by a phylogroup-independent searching approach. ISME J. 2011; 5: 519-531.
85. Backhed F, Ley RE, Sonnenburg JL, et al. Host-bacterial mutualism in the human intestine. Science. 2005; 307: 1915-1920. (Pubitemid 40404694)
86. Ley RE, Backhed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005; 102: 11070-11075. (Pubitemid 41105994)
87. Turnbaugh PJ, Ridaura VK, Faith JJ, et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2009; 1: 6ra14.
88. Van de Merwe JP, Stegeman JH, Hazenberg MP,. The resident faecal flora is determined by genetic characteristics of the host. Implications for Crohn's disease? Antonie Van Leeuwenhoek. 1983; 49: 119-124. (Pubitemid 13045727)
89. Stewart JA, Chadwick VS, Murray A,. Investigations into the influence of host genetics on the predominant eubacteria in the faecal microflora of children. J Med Microbiol. 2005; 54: 1239-12342.
90. Zoetendal EG, Akkermans ADL, Akkermans-van Vliet WM, et al. The host genotype affects the bacterial community in the human gastroinestinal tract. Microb Ecol Health Dis. 2001; 13: 129-134. (Pubitemid 32905860)
91. Willing B, Dicksved J, Halfvarson J, et al. A pyrosequencing study in twins shows that GI microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology. 2010; 139: 1844-1854.
92. Rawls JF, Mahowald MA, Ley RE, et al. Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell. 2006; 127: 423-433. (Pubitemid 44572375)
93. Grehan MJ, Borody TJ, Leis SM, et al. Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol. 2010; 44: 551-561.
94. Frank DN, Robertson CE, Hamm CM, et al. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis. 2011; 17: 179-184.
95. Fritz T, Niederreiter L, Adolph T, et al. Crohn's disease: NOD2, autophagy and ER stress converge. Gut. 2011; [Epub ahead of print].
96. Vaishnava S, Behrendt CL, Ismail AS, et al. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci U S A. 2008; 105: 20858-20863.
97. Garrett WS, Gordon JI, Glimcher LH,. Homeostasis and inflammation in the intestine. Cell. 2010; 140: 859-870.
98. Kaser A, Blumberg RS,. Endoplasmic reticulum stress in the intestinal epithelium and inflammatory bowel disease. Semin Immunol. 2009; 21: 156-163.
99. Kaser A, Blumberg RS,. Paneth cells and inflammation dance together in Crohn's disease. Cell Res. 2008; 18: 1160-1162.
100. Kaser A, Lee AH, Franke A, et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell. 2008; 134: 743-756.
101. Kaser A, Martinez-Naves E, Blumberg RS,. Endoplasmic reticulum stress: implications for inflammatory bowel disease pathogenesis. Curr Opin Gastroenterol. 2010; 26: 318-326.
102. Cadwell K, Liu JY, Brown SL, et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature. 2008; 456: 259-263.
103. Uronis JM, Muhlbauer M, Herfarth HH, et al. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One. 2009; 4: e6026.
104. Petnicki-Ocwieja T, Hrncir T, Liu YJ, et al. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci U S A. 2009; 106: 15813-15818.
105. Cho JH,. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol. 2008; 8: 458-466. (Pubitemid 351733422)
106. Kobayashi KS, Chamaillard M, Ogura Y, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science. 2005; 307: 731-734. (Pubitemid 40194644)
107. Begue B, Dumant C, Bambou JC, et al. Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop. J Cell Physiol. 2006; 209: 241-252. (Pubitemid 44484613)
108. Wehkamp J, Salzman NH, Porter E, et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A. 2005; 102: 18129-18134. (Pubitemid 41798513)
109. Simms LA, Doecke JD, Walsh MD, et al. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut. 2008; 57: 903-910. (Pubitemid 351919524)
110. Bevins CL, Stange EF, Wehkamp J,. Decreased Paneth cell defensin expression in ileal Crohn's disease is independent of inflammation, but linked to the NOD2 1007fs genotype. Gut. 2009; 58: 882-883; discussion 3-4.
111. Bouskra D, Brezillon C, Berard M, et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature. 2008; 456: 507-510. (Pubitemid 352759006)
112. Hooper LV, Macpherson AJ,. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol. 2010; 10: 159-169.
113. Eberl G, Lochner M,. The development of intestinal lymphoid tissues at the interface of self and microbiota. Mucosal Immunol. 2009; 2: 478-485.
114. Cerf-Bensussan N, Gaboriau-Routhiau V,. The immune system and the gut microbiota: friends or foes? Nat Rev Immunol. 2010; 10: 735-744.
115. Stagg AJ, Hart AL, Knight SC, et al. Microbial-gut interactions in health and disease. Interactions between dendritic cells and bacteria in the regulation of intestinal immunity. Best Pract Res Clin Gastroenterol. 2004; 18: 255-270. (Pubitemid 38444129)
116. Ng SC, Benjamin JL, McCarthy NE, et al. Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease. Inflamm Bowel Dis. 2010; [Epub ahead of print].
117. Glocker EO, Kotlarz D, Boztug K, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009; 361: 2033-2045.
118. Round JL, Mazmanian SK,. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A. 2010; 107: 12204-12209.
119. Mazmanian SK, Round JL, Kasper DL,. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 2008; 453: 620-625. (Pubitemid 351769307)
120. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008; 105: 16731-16736.
121. Ivanov II, Frutos Rde L, Manel N, et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe. 2008; 4: 337-349.
122. Lakhdari O, Cultrone A, Tap J, et al. Functional metagenomics: a high throughput screening method to decipher microbiota-driven NF-kappaB modulation in the human gut. PLoS One. 2010; 5.
123. Clarke TB, Davis KM, Lysenko ES, et al. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med. 2010; 16: 228-231.
124. Mazmanian SK, Liu CH, Tzianabos AO, et al. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 2005; 122: 107-118. (Pubitemid 40977944)
125. Maslowski KM, Vieira AT, Ng A, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009; 461: 1282-1286.
126. Sokol H, Lepage P, Seksik P, et al. Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis. Gut. 2007; 56: 152-154. (Pubitemid 46044904)
127. Sokol H, Seksik P, Rigottier-Gois L, et al. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis. 2006; 12: 106-111.
128. Swidsinski A, Weber J, Loening-Baucke V, et al. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol. 2005; 43: 3380-3389. (Pubitemid 40981351)
129. Darfeuille-Michaud A, Neut C, Barnich N, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology. 1998; 115: 1405-1413. (Pubitemid 28545991)
130. Kirkwood CD, Wagner J, Boniface K, et al. Mycobacterium avium subspecies paratuberculosis in children with early-onset Crohn's disease. Inflamm Bowel Dis. 2009; 15: 1643-1655.
131. Ruseler-van Embden JG, Both-Patoir HC,. Anaerobic gram-negative faecal flora in patients with Crohn's disease and healthy subjects. Antonie Van Leeuwenhoek. 1983; 49: 125-132.
132. Martin HM, Campbell BJ, Hart CA, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology. 2004; 127: 80-93. (Pubitemid 38962277)
133. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002; 122: 44-54. (Pubitemid 34049193)
134. Kleessen B, Kroesen AJ, Buhr HJ, et al. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol. 2002; 37: 1034-1041.
135. Schultsz C, Van Den Berg FM, Ten Kate FW, et al. The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology. 1999; 117: 1089-1097. (Pubitemid 29512667)
136. Conte MP, Schippa S, Zamboni I, et al. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut. 2006; 55: 1760-1767. (Pubitemid 44893575)
137. Swidsinski A, Loening-Baucke V, Lochs H, et al. Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice. World J Gastroenterol. 2005; 11: 1131-1140. (Pubitemid 40352998)
138. Prindiville T, Cantrell M, Wilson KH,. Ribosomal DNA sequence analysis of mucosa-associated bacteria in Crohn's disease. Inflamm Bowel Dis. 2004; 10: 824-833. (Pubitemid 39545228)
139. Gophna U, Charlebois RL, Doolittle WF,. Ancient lateral gene transfer in the evolution of Bdellovibrio bacteriovorus. Trends Microbiol. 2006; 14: 64-69. (Pubitemid 43190735)
140. Ohkusa T, Sato N, Ogihara T, et al. Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species-specific antibody. J Gastroenterol Hepatol. 2002; 17: 849-853.
141. Matsuda H, Fujiyama Y, Andoh A, et al. Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis. J Gastroenterol Hepatol. 2000; 15: 61-68. (Pubitemid 30140928)
142. Scanlan PD, Shanahan F, O'Mahony C, et al. Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. J Clin Microbiol. 2006; 44: 3980-3988. (Pubitemid 44737239)
143. Ott SJ, Musfeldt M, Wenderoth DF, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 2004; 53: 685-693. (Pubitemid 38561447)
144. Dicksved J, Halfvarson J, Rosenquist M, et al. Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J. 2008; 2: 716-727. (Pubitemid 351951567)
145. Walker AW, Sanderson JD, Churcher C, et al. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol. 2011; 11: 7.
146. Martinez C, Antolin M, Santos J, et al. Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission. Am J Gastroenterol. 2008; 103: 643-648. (Pubitemid 351405965)
147. Ott SJ, Plamondon S, Hart A, et al. Dynamics of the mucosa-associated flora in ulcerative colitis patients during remission and clinical relapse. J Clin Microbiol. 2008; 46: 3510-3513.
148. Noor SO, Ridgway K, Scovell L, et al. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol. 2010; 10: 134.
149. Gophna U, Sommerfeld K, Gophna S, et al. Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J Clin Microbiol. 2006; 44: 4136-4141. (Pubitemid 44737260)
150. Swidsinski A, Loening-Baucke V, Vaneechoutte M, et al. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis. 2008; 14: 147-161. (Pubitemid 351288036)
151. Schwiertz A, Jacobi M, Frick JS, et al. Microbiota in pediatric inflammatory bowel disease. J Pediatr. 2010; 157: 240-244.
152. Martinez-Medina M, Aldeguer X, Gonzalez-Huix F, et al. Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis. Inflamm Bowel Dis. 2006; 12: 1136-1145. (Pubitemid 44847471)
153. Willing B, Halfvarson J, Dicksved J, et al. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis. 2009; 15: 653-660.
154. Hayashi H, Sakamoto M, Kitahara M, et al. Molecular analysis of fecal microbiota in elderly individuals using 16S rDNA library and T-RFLP. Microbiol Immunol. 2003; 47: 557-570. (Pubitemid 37010383)
155. Kang S, Denman SE, Morrison M, et al. Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray. Inflamm Bowel Dis. 2010; 16: 2034-2042.
156. Mondot S, Kang S, Furet JP, et al. Highlighting new phylogenetic specificities of crohn's disease microbiota. Inflamm Bowel Dis. 2010; 17: 185-192.
157. Aguirre De Carcer D, Cuiv PO, Wang T, et al. Application of numerical ecology methods to microarray data reveals obscured patterns in the mucosa associated microbial community of the human colorectum. J Gastroenterol Hepatol. 2009; 24: A241.
158. Andoh A, Sakata S, Koizumi Y, et al. Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis. Inflamm Bowel Dis. 2007; 13: 955-962. (Pubitemid 47309966)
159. Christophersen CT, Kang S, McSweeney CS, et al. The gut microflora of individuals with ulcerative colitis (remission or mild) differs from healthy individuals. J Gastroenterol Hepatol. 2009; 24: A320.
160. Dabard J, Bridonneau C, Phillipe C, et al. Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces. Appl Environ Microbiol. 2001; 67: 4111-4118. (Pubitemid 33641706)
161. Png CW, Linden SK, Gilshenan KS, et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol. 2010; 105: 2420-2428.
162. Giaffer MH, Holdsworth CD, Duerden BI,. Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease. Gut. 1992; 33: 646-650.
163. Kotlowski R, Bernstein CN, Sepehri S, et al. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut. 2007; 56: 669-675. (Pubitemid 46662933)
164. Mylonaki M, Rayment NB, Rampton DS, et al. Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. Inflamm Bowel Dis. 2005; 11: 481-487. (Pubitemid 40704083)
165. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology. 2004; 127: 412-421. (Pubitemid 39091889)
166. Fujita H, Eishi Y, Ishige I, et al. Quantitative analysis of bacterial DNA from Mycobacteria spp., Bacteroides vulgatus, and Escherichia coli in tissue samples from patients with inflammatory bowel diseases. J Gastroenterol. 2002; 37: 509-516.
167. Mangin I, Bonnet R, Seksik P, et al. Molecular inventory of faecal microflora in patients with Crohn's disease. FEMS Microbiol Ecol. 2004; 50: 25-36. (Pubitemid 39265393)
168. Giaffer MH, Holdsworth CD, Duerden BI,. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. J Med Microbiol. 1991; 35: 238-243.
169. Bullock NR, Booth JC, Gibson GR,. Comparative composition of bacteria in the human intestinal microflora during remission and active ulcerative colitis. Curr Issues Intest Microbiol. 2004; 5: 59-64. (Pubitemid 39248267)
170. Kuehbacher T, Rehman A, Lepage P, et al. Intestinal TM7 bacterial phylogenies in active inflammatory bowel disease. J Med Microbiol. 2008; 57: 1569-1576.
171. Joossens M, Huys G, Cnockaert M, et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut. 2011; 60: 631-637.
172. Dalsiel TK,. Chronic intestinal enteritis. Br Med J 1913: 1068-1070.
173. Feller M, Huwiler K, Stephan R, et al. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect Dis. 2007; 7: 607-613. (Pubitemid 47268226)
174. Abubakar I, Myhill D, Aliyu SH, et al. Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques: a systematic review and meta-analysis. Inflamm Bowel Dis. 2008; 14: 401-410. (Pubitemid 351441331)
175. Frank DN,. Mycobacterium avium subspecies paratuberculosis and Crohn's disease. Lancet Infect Dis. 2008; 8: 345; author reply 346. (Pubitemid 351697799)
176. Greenstein RJ, Su L, Haroutunian V, et al. On the action of methotrexate and 6-mercaptopurine on M. avium subspecies paratuberculosis. PLoS One. 2007; 2: e161.
177. Greenstein RJ, Su L, Shahidi A, et al. On the action of 5-amino-salicylic acid and sulfapyridine on M. avium including subspecies paratuberculosis. PLoS One. 2007; 2: e516.
178. Borgaonkar M, MacIntosh D, Fardy J, et al. Anti-tuberculous therapy for maintaining remission of Crohn's disease. Cochrane Database Syst Rev. 2000; CD000299.
179. Selby W, Pavli P, Crotty B, et al. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. Gastroenterology. 2007; 132: 2313-2319. (Pubitemid 46890859)
180. Lederman E, Neut C, Desreumaux P,. Bacterial overgrowth in the neoterminal ileum after ileocolonic resection for Crohn's disease. Gastroenterology. 1997; 112.
181. Neut C, Bulois P, Desreumaux P, et al. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. Am J Gastroenterol. 2002; 97: 939-946. (Pubitemid 34408252)
182. Rolhion N, Darfeuille-Michaud A,. Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis. 2007; 13: 1277-1283. (Pubitemid 47597778)
183. Kaper JB, Nataro JP, Mobley HL,. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004; 2: 123-140. (Pubitemid 39490066)
184. Boudeau J, Barnich N, Darfeuille-Michaud A,. Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells. Mol Microbiol. 2001; 39: 1272-1284. (Pubitemid 32225137)
185. Barnich N, Boudeau J, Claret L, et al. Regulatory and functional co-operation of flagella and type 1 pili in adhesive and invasive abilities of AIEC strain LF82 isolated from a patient with Crohn's disease. Mol Microbiol. 2003; 48: 781-794. (Pubitemid 36819062)
186. Claret L, Miquel S, Vieille N, et al. The flagellar sigma factor FliA regulates adhesion and invasion of Crohn disease-associated Escherichia coli via a cyclic dimeric GMP-dependent pathway. J Biol Chem. 2007; 282: 33275-33283. (Pubitemid 350159501)
187. Rolhion N, Carvalho FA, Darfeuille-Michaud A,. OmpC and the sigma(E) regulatory pathway are involved in adhesion and invasion of the Crohn's disease-associated Escherichia coli strain LF82. Mol Microbiol. 2007; 63: 1684-1700. (Pubitemid 46426710)
188. Barnich N, Bringer MA, Claret L, et al. Involvement of lipoprotein NlpI in the virulence of adherent invasive Escherichia coli strain LF82 isolated from a patient with Crohn's disease. Infect Immun. 2004; 72: 2484-2493. (Pubitemid 38542373)
189. Bringer MA, Rolhion N, Glasser AL, et al. The oxidoreductase DsbA plays a key role in the ability of the Crohn's disease-associated adherent-invasive Escherichia coli strain LF82 to resist macrophage killing. J Bacteriol. 2007; 189: 4860-48671.
190. Pineton de Chambrun G, Colombel JF, Poulain D, et al. Pathogenic agents in inflammatory bowel diseases. Curr Opin Gastroenterol. 2008; 24: 440-447.
191. Lapaquette P, Glasser AL, Huett A, et al. Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol. 2010; 12: 99-113.
192. Barnich N, Carvalho FA, Glasser AL, et al. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest. 2007; 117: 1566-1574. (Pubitemid 46871341)
193. Glasser AL, Boudeau J, Barnich N, et al. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect Immun. 2001; 69: 5529-5537. (Pubitemid 32786488)
194. Peeters H, Bogaert S, Laukens D, et al. CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease. Int J Immunogenet. 2007; 34: 181-191. (Pubitemid 46763548)
195. Wagner J, Short K, Catto-Smith AG, et al. Identification and characterisation of Pseudomonas 16S ribosomal DNA from ileal biopsies of children with Crohn's disease. PLoS One. 2008; 3: e3578.
196. Parent K, Mitchell P,. Cell wall-defective variants of pseudomonas-like (group Va) bacteria in Crohn's disease. Gastroenterology. 1978; 75: 368-372. (Pubitemid 8389349)
197. Sutton CL, Kim J, Yamane A, et al. Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology. 2000; 119: 23-31. (Pubitemid 30452575)
198. Spivak J, Landers CJ, Vasiliauskas EA, et al. Antibodies to I2 predict clinical response to fecal diversion in Crohn's disease. Inflamm Bowel Dis. 2006; 12: 1122-1130. (Pubitemid 44847469)
199. Madi A, Lakhdari O, Blottiere HM, et al. The clinical Pseudomonas fluorescens MFN1032 strain exerts a cytotoxic effect on epithelial intestinal cells and induces Interleukin-8 via the AP-1 signaling pathway. BMC Microbiol. 2010; 10: 215.
200. Kallinowski F, Wassmer A, Hofmann MA, et al. Prevalence of enteropathogenic bacteria in surgically treated chronic inflammatory bowel disease. Hepatogastroenterology. 1998; 45: 1552-1558. (Pubitemid 28515158)
201. Lamps LW, Madhusudhan KT, Havens JM, et al. Pathogenic Yersinia DNA is detected in bowel and mesenteric lymph nodes from patients with Crohn's disease. Am J Surg Pathol. 2003; 27: 220-227. (Pubitemid 36152232)
202. Huijsdens XW, Linskens RK, Taspinar H, et al. Listeria monocytogenes and inflammatory bowel disease: detection of Listeria species in intestinal mucosal biopsies by real-time PCR. Scand J Gastroenterol. 2003; 38: 332-333. (Pubitemid 36469996)
203. Chen W, Li D, Paulus B, et al. Detection of Listeria monocytogenes by polymerase chain reaction in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls. J Gastroenterol Hepatol. 2000; 15: 1145-1150.
204. Brown WR,. Listeria: the latest putative pathogenetic microorganism in Crohn's disease. Gastroenterology. 1995; 108: 1589-1590.
205. Sim WH, Wagner J, Cameron DJ, et al. Novel Burkholderiales 23S rRNA genes identified in ileal biopsy samples from children: preliminary evidence that a subtype is associated with perianal Crohn's disease. J Clin Microbiol. 2010; 48: 1939-1942.
206. Chow J, Mazmanian SK,. A pathobiont of the microbiota balances host colonization and intestinal inflammation. Cell Host Microbe. 2010; 7: 265-276.
207. Man SM, Zhang L, Day AS, et al. Detection of enterohepatic and gastric helicobacter species in fecal specimens of children with Crohn's disease. Helicobacter. 2008; 13: 234-238.
208. Oliveira AG, Rocha GA, Rocha AM, et al. Isolation of Helicobacter pylori from the intestinal mucosa of patients with Crohn's disease. Helicobacter. 2006; 11: 2-9.
209. Cahill RJ, Foltz CJ, Fox JG, et al. Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect Immun. 1997; 65: 3126-3131. (Pubitemid 27342388)
210. Laharie D, Asencio C, Asselineau J, et al. Association between entero-hepatic Helicobacter species and Crohn's disease: a prospective cross-sectional study. Aliment Pharmacol Ther. 2009; 30: 283-293.
211. Cadwell K, Patel KK, Maloney NS, et al. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell. 2010; 141: 1135-1145.
212. Peterson DA, Turnbaugh PJ,. A microbe-dependent viral key to Crohn's box. Sci Transl Med. 2010; 2: 43ps39.
213. Smith MS, Wakefield AJ,. Viral association with Crohn's disease. Ann Med. 1993; 25: 557-561. (Pubitemid 24027009)
214. Rehaume LM, Jouault T, Chamaillard M,. Lessons from the inflammasome: a molecular sentry linking Candida and Crohn's disease. Trends Immunol. 2010; 31: 171-175.
215. Standaert-Vitse A, Sendid B, Joossens M, et al. Candida albicans colonization and ASCA in familial Crohn's disease. Am J Gastroenterol. 2009; 104: 1745-1753.
216. Ott SJ, Kuhbacher T, Musfeldt M, et al. Fungi and inflammatory bowel diseases: Alterations of composition and diversity. Scand J Gastroenterol. 2008; 43: 831-841. (Pubitemid 351918525)
217. van der Waaij LA, Harmsen HJ, Madjipour M, et al. Bacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes: commensal bacteria live in suspension and have no direct contact with epithelial cells. Inflamm Bowel Dis. 2005; 11: 865-871. (Pubitemid 41428844)
218. Bibiloni R, Tandon P, Vargas-Voracka F, et al. Differential clustering of bowel biopsy-associated bacterial profiles of specimens collected in Mexico and Canada: what do these profiles represent? J Med Microbiol. 2008; 57: 111-117.
219. Ian MC, Temitope OK, Tamar R-K, et al. T2065 Molecular characterization of the fecal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant IBS and healthy subjects. Gastroenterology. 2010; 138: S-624.
220. Lepage P, Mondot S, Vasquez N, et al, Bacterial Recolonization after Gut Resection for Crohn's DIsease: Uniformity as an Essential Factor Toward Remission. Gut; 2009: 58 (Suppl II) OPO20.
221. Ahmed S, Macfarlane GT, Fite A, et al. Mucosa-associated bacterial diversity in relation to human terminal ileum and colonic biopsy samples. Appl Environ Microbiol. 2007; 73: 7435-7442. (Pubitemid 350196697)
222. Bibiloni R, Mangold M, Madsen KL, et al. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol. 2006; 55: 1141-1149. (Pubitemid 44215574)
223. Valerio I, Monica Proietti C, Valentina T, et al. T1811 Dominant Intestinal Mucosa-Associated Microbiota in Pediatric Patients With Inflammatory Bowel Disease. Gastroenterology. 2010; 138: S583-S584.
224. Hayashi H, Takahashi R, Nishi T, et al. Molecular analysis of jejunal, ileal, caecal and recto-sigmoidal human colonic microbiota using 16S rRNA gene libraries and terminal restriction fragment length polymorphism. J Med Microbiol. 2005; 54: 1093-1101. (Pubitemid 41566781)
225. Wang X, Heazlewood SP, Krause DO, et al. Molecular characterization of the microbial species that colonize human ileal and colonic mucosa by using 16S rDNA sequence analysis. J Appl Microbiol. 2003; 95: 508-5020.
226. de Carcer DA, Cuiv PO, Wang T, et al. Numerical ecology validates a biogeographical distribution and gender-based effect on mucosa-associated bacteria along the human colon. ISME J. 2010; [Epub ahead of print].
227. Seungha K, Arun G, Josef W, et al. T1805 Analysis of the Mucosal Microbiota From Inflammatory Bowel Disease Biopsy Tissues Using a Custom 16s rRNA Based Phylogenetic Microarray. Gastroenterology. 2010; 138: S-582.
228. Zhang M, Liu B, Zhang Y, et al. Structural shifts of mucosa-associated lactobacilli and Clostridium leptum subgroup in patients with ulcerative colitis. J Clin Microbiol. 2007; 45: 496-500.
229. Seksik P, Lepage P, de la Cochetiere MF, et al. Search for localized dysbiosis in Crohn's disease ulcerations by temporal temperature gradient gel electrophoresis of 16S rRNA. J Clin Microbiol. 2005; 43: 4654-4658. (Pubitemid 41298258)
230. Vasquez N, Mangin I, Lepage P, et al. Patchy distribution of mucosal lesions in ileal Crohn's disease is not linked to differences in the dominant mucosa-associated bacteria: a study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis. Inflamm Bowel Dis. 2007; 13: 684-692. (Pubitemid 46909982)
231. Sepehri S, Kotlowski R, Bernstein CN, et al. Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm Bowel Dis. 2007; 13: 675-683. (Pubitemid 46909981)
232. Rajilic-Stojanovic M, Heilig HG, Molenaar D, et al. Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ Microbiol. 2009; 11: 1736-1751.
233. Matsuki T, Watanabe K, Fujimoto J, et al. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol. 2004; 70: 7220-7228. (Pubitemid 39643786)
234. Ley RE, Turnbaugh PJ, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature. 2006; 444: 1022-1023. (Pubitemid 46018512)
235. Andoh A, Imaeda H, Aomatsu T, et al. Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis. J Gastroenterol. 2011; [Epub ahead of print].
236. Madden MV, McIntyre AS, Nicholls RJ,. Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci. 1994; 39: 1193-1196. (Pubitemid 24190255)
237. Gionchetti P, Rizzello F, Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology. 2003; 124: 1202-1209. (Pubitemid 36531796)
238. Nasmyth DG, Godwin PG, Dixon MF, et al. Ileal ecology after pouch-anal anastomosis or ileostomy. A study of mucosal morphology, fecal bacteriology, fecal volatile fatty acids, and their interrelationship. Gastroenterology. 1989; 96: 817-824. (Pubitemid 19057605)
239. Smith FM, Coffey JC, Kell MR, et al. A characterization of anaerobic colonization and associated mucosal adaptations in the undiseased ileal pouch. Colorectal Dis. 2005; 7: 563-570. (Pubitemid 41631616)
240. Loeschke K, Bolkert T, Kiefhaber P, et al. Bacterial overgrowth in ileal reservoirs (Koch pouch): extended functional studies. Hepatogastroenterology. 1980; 27: 310-316. (Pubitemid 10056098)
241. McLaughlin SD, Walker AW, Churcher C, et al. The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing. Ann Surg. 2010; 252: 90-98.
242. Komanduri S, Gillevet PM, Sikaroodi M, et al. Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation. Clin Gastroenterol Hepatol. 2007; 5: 352-360. (Pubitemid 46401536)
243. Zella GC, Hait EJ, Glavan T, et al. Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis. Inflamm Bowel Dis. 2010; [Epub ahead of print].
244. Tringe SG, Rubin EM,. Metagenomics: DNA sequencing of environmental samples. Nat Rev Genet. 2005; 6: 805-814.
245. Kurokawa K, Itoh T, Kuwahara T, et al. Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res. 2007; 14: 169-181.
246. Tasse L, Bercovici J, Pizzut-Serin S, et al. Functional metagenomics to mine the human gut microbiome for dietary fiber catabolic enzymes. Genome Res. 2010; 20: 1605-1612.
247. Rehman A, Lepage P, Nolte A, et al. Transcriptional activity of the dominant gut mucosal microbiota in chronic inflammatory bowel disease patients. J Med Microbiol. 2010; 59: 1114-1122.
248. Mondot S, Lepage P, Coehlo J, et al. P0904 Functionality of the gut mucosal microbiota: an -omics vision of the Crohn's disease microbiome. Gut. 2010; 59: A289.
249. Kussmann M, Raymond F, Affolter M,. OMICS-driven biomarker discovery in nutrition and health. J Biotechnol. 2006; 124: 758-787. (Pubitemid 44088435)
250. Klaassens ES, de Vos WM, Vaughan EE,. Metaproteomics approach to study the functionality of the microbiota in the human infant gastrointestinal tract. Appl Environ Microbiol. 2007; 73: 1388-1392.
251. Verberkmoes NC, Russell AL, Shah M, et al. Shotgun metaproteomics of the human distal gut microbiota. ISME J. 2009; 3: 179-189.
252. Ang CS, Phung J, Nice EC,. The discovery and validation of colorectal cancer biomarkers. Biomed Chromatogr. 2011; 25: 82-99.
253. Horgan RP, Clancy OH, Myers JE, et al. An overview of proteomic and metabolomic technologies and their application to pregnancy research. BJOG. 2009; 116: 173-181.
254. Nicholson JK, Wilson ID,. Opinion: understanding /global/ systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov. 2003; 2: 668-676. (Pubitemid 37361770)
255. Bjerrum JT, Nielsen OH, Hao F, et al. Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and insight into the pathophysiology. J Proteome Res. 2010; 9: 954-962.
256. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007; 447: 661-678.
257. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007; 445: 881-885.
258. Holmes E, Loo RL, Stamler J, et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature. 2008; 453: 396-400. (Pubitemid 351693125)
259. Bictash M, Ebbels TM, Chan Q, et al. Opening up the "Black Box": metabolic phenotyping and metabolome-wide association studies in epidemiology. J Clin Epidemiol. 2010; 63: 970-979.
260. Slupsky CM, Rankin KN, Wagner J,. Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal Chem. 2007; 79: 6995-7004. (Pubitemid 47438678)
261. Psihogios NG, Gazi IF, Elisaf MS,. Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomics. NMR Biomed. 2008; 21: 195-207. (Pubitemid 351513667)
262. Walsh MC, Brennan L, Malthouse JP,. Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. Am J Clin Nutr. 2006; 84: 531-539. (Pubitemid 44713402)
263. Lenz EM, Bright J, Wilson ID,. A 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. J Pharm Biomed Anal. 2003; 33: 1103-1115. (Pubitemid 37501013)
264. Varma S, Eskin MN, Bird R, et al. Potential of magnetic resonance spectroscopy in assessing the effect of fatty acids on inflammatory bowel disease in an animal model. Lipids. 2010; 45: 843-854.
265. Stella C, Beckwith-Hall B, Cloarec O,. Susceptibility of human metabolic phenotypes to dietary modulation. J Proteome Res. 2006; 5: 2780-2788. (Pubitemid 44604232)
266. Romick-Rosendale LE, Goodpaster AM, Hanwright PJ, et al. NMR-based metabonomics analysis of mouse urine and fecal extracts following oral treatment with the broad-spectrum antibiotic enrofloxacin (Baytril). Magn Reson Chem. 2009; 47 (suppl 1): S36-46.
267. Jansson J, Willing B, Lucio M, et al. Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS One. 2009; 4: e6386.
268. Marchesi JR, Holmes E, Khan F, et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007; 6: 546-551. (Pubitemid 46340158)
269. Williams RE, Eyton-Jones HW, Farnworth MJ,. Effect of intestinal microflora on the urinary metabolic profile of rats: a 1H-nuclear magnetic resonance spectroscopy study. Xenobiotica. 2002; 32: 783-794.
270. Nicholls AW, Mortishire-Smith RJ, Nicholson JK,. NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chem Res Toxicol. 2003; 16: 1395-404. (Pubitemid 37464460)
271. Williams HR, Cox IJ, Walker DG, et al. Characterization of inflammatory bowel disease with urinary metabolic profiling. Am J Gastroenterol. 2009; 104: 1435-1444.
272. Balasubramanian K, Kumar S, Singh RR, et al. Metabolism of the colonic mucosa in patients with inflammatory bowel diseases: an in vitro proton magnetic resonance spectroscopy study. Magn Reson Imaging. 2009; 27: 79-86.
273. Bezabeh T, Somorjai RL, Smith IC, et al. The use of 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease. Am J Gastroenterol. 2001; 96: 442-448.
274. Sharma U, Singh RR, Ahuja V, et al. Similarity in the metabolic profile in macroscopically involved and un-involved colonic mucosa in patients with inflammatory bowel disease: an in vitro proton ((1)H) MR spectroscopy study. Magn Reson Imaging. 2010; 28: 1022-1029.
275. Mueller S, Saunier K, Hanisch C, et al. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol. 2006; 72: 1027-1033. (Pubitemid 43271206)
276. Lay C, Rigottier-Gois L, Holmstrom K, et al. Colonic microbiota signatures across five northern European countries. Appl Environ Microbiol. 2005; 71: 4153-4155. (Pubitemid 40980596)
277. Sepp E, Julge K, Vasar M, et al. Intestinal microflora of Estonian and Swedish infants. Acta Paediatr. 1997; 86: 956-961. (Pubitemid 27425591)
278. Mah KW, Sangsupawanich P, Tunyapanit W, et al. Gut microbiota of children living in rural south Thailand and urban Singapore. Allergol Int. 2008; 57: 65-71. (Pubitemid 351413246)
279. De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010; 107: 14691-14696.
280. Flint HJ, Duncan SH, Scott KP, et al. Interactions and competition within the microbial community of the human colon: links between diet and health. Environ Microbiol. 2007; 9: 1101-1111. (Pubitemid 46697267)
281. Bernstein CN, Shanahan F,. Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut. 2008; 57: 1185-1191.
282. Thia KT, Loftus EV Jr, Sandborn WJ, et al. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008; 103: 3167-3182.
283. Ley RE,. Obesity and the human microbiome. Curr Opin Gastroenterol. 2010; 26: 5-11.
284. Cani PD, Possemiers S, Van de Wiele T, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009; 58: 1091-1103.
285. Nguyen KA, Cao Y, Chen JR, et al., Dietary fiber enhances a tumor suppressor signaling pathway in the gut. Ann Surg. 2006; 243: 619-625; discussion 25-27. (Pubitemid 44305573)
286. Roy CC, Kien CL, Bouthillier L, et al. Short-chain fatty acids: ready for prime time? Nutr Clin Pract. 2006; 21: 351-366.
287. Macfarlane S, Macfarlane GT,. Regulation of short-chain fatty acid production. Proc Nutr Soc. 2003; 62: 67-72.
288. Vanhoutvin SA, Troost FJ, Hamer HM, et al. Butyrate-induced transcriptional changes in human colonic mucosa. PLoS One. 2009; 4: e6759.
289. Louis P, Scott KP, Duncan SH, et al. Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol. 2007; 102: 1197-1208. (Pubitemid 46633434)
290. Barcenilla A, Pryde SE, Martin JC, et al. Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol. 2000; 66: 1654-1661. (Pubitemid 30185646)
291. Hold GL, Schwiertz A, Aminov RI, et al. Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl Environ Microbiol. 2003; 69: 4320-4324. (Pubitemid 36870105)
292. Aminov RI, Walker AW, Duncan SH, et al. Molecular diversity, cultivation, and improved detection by fluorescent in situ hybridization of a dominant group of human gut bacteria related to Roseburia spp. or Eubacterium rectale. Appl Environ Microbiol. 2006; 72: 6371-6376. (Pubitemid 44414672)
293. Van Loo J,. The specificity of the interaction with intestinal bacterial fermentation by prebiotics determines their physiological efficacy. Nutr Res Rev. 2004; 17: 89-98. (Pubitemid 38901942)
294. Sokol H, Seksik P, Furet JP, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009; 15: 1183-1189.
295. Kanauchi O, Suga T, Tochihara M, et al. Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial. J Gastroenterol. 2002; 37 Suppl 14: 67-72. (Pubitemid 35385930)
296. Breuer RI, Soergel KH, Lashner BA, et al. Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial. Gut. 1997; 40: 485-491. (Pubitemid 27204928)
297. Galvez J, Rodriguez-Cabezas ME, Zarzuelo A,. Effects of dietary fiber on inflammatory bowel disease. Mol Nutr Food Res. 2005; 49: 601-608. (Pubitemid 40853706)
298. Attene-Ramos MS, Wagner ED, Gaskins HR, et al. Hydrogen sulfide induces direct radical-associated DNA damage. Mol Cancer Res. 2007; 5: 455-459. (Pubitemid 46903954)
299. Gardiner KR, Halliday MI, Barclay GR, et al. Significance of systemic endotoxaemia in inflammatory bowel disease. Gut. 1995; 36: 897-901.
300. Roediger WE, Moore J, Babidge W,. Colonic sulfide in pathogenesis and treatment of ulcerative colitis. Dig Dis Sci. 1997; 42: 1571-1579. (Pubitemid 27394576)
301. Sharma S, O'Keefe SJ,. Environmental influences on the high mortality from colorectal cancer in African Americans. Postgrad Med J. 2007; 83: 583-589. (Pubitemid 47425609)
302. O'Keefe SJ,. The African way of life and colon cancer risk. Am J Gastroenterol. 2001; 96: 3220-3221. (Pubitemid 33095381)
303. O'Keefe SJ,. Nutrition and colonic health: the critical role of the microbiota. Curr Opin Gastroenterol. 2008; 24: 51-58. (Pubitemid 350190898)
304. Magee EA, Richardson CJ, Hughes R, et al. Contribution of dietary protein to sulfide production in the large intestine: an in vitro and a controlled feeding study in humans. Am J Clin Nutr. 2000; 72: 1488-1494.
305. O'Keefe SJ, Chung D, Mahmoud N, et al. Why do African Americans get more colon cancer than Native Africans? J Nutr. 2007; 137: 175S-182S. (Pubitemid 46070105)
306. O'Keefe SJ, Ou J, Aufreiter S, et al. Products of the colonic microbiota mediate the effects of diet on colon cancer risk. J Nutr. 2009; 139: 2044-2048.
307. Hehemann JH, Correc G, Barbeyron T, et al. Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature. 2010; 464: 908-912.
308. Sakamoto N, Kono S, Wakai K, et al. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis. 2005; 11: 154-163. (Pubitemid 40711220)
309. Amre DK, D'Souza S, Morgan K, et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol. 2007; 102: 2016-2025. (Pubitemid 47301536)
310. Geerling BJ, Dagnelie PC, Badart-Smook A, et al. Diet as a risk factor for the development of ulcerative colitis. Am J Gastroenterol. 2000; 95: 1008-1013. (Pubitemid 30196738)
311. Jowett SL, Seal CJ, Pearce MS, et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut. 2004; 53: 1479-1484. (Pubitemid 39265269)
312. Tragnone A, Valpiani D, Miglio F, et al. Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1995; 7: 47-51.
313. Persson PG, Ahlbom A, Hellers G,. Diet and inflammatory bowel disease: a case-control study. Epidemiology. 1992; 3: 47-52.
314. Loftus EV Jr,. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004; 126: 1504-1517. (Pubitemid 38649869)
315. Gilat T, Hacohen D, Lilos P, et al. Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scand J Gastroenterol. 1987; 22: 1009-1024. (Pubitemid 17152843)
316. Russel MG, Engels LG, Muris JW, et al. Modern life in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol. 1998; 10: 243-249. (Pubitemid 28175002)
317. Reif S, Klein I, Lubin F, et al. Pre-illness dietary factors in inflammatory bowel disease. Gut. 1997; 40: 754-760. (Pubitemid 27305468)
318. Halfvarson J, Jess T, Magnuson A, et al. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis. 2006; 12: 925-933. (Pubitemid 44498280)
319. Baron S, Turck D, Leplat C, et al. Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut. 2005; 54: 357-363. (Pubitemid 40299091)
320. Matsuura M, Liu B, Carroll I, et al. Selective alteration of growth and virulence for iron-dependent bacterial species; possible novel mechanisms of detrimental effects of dietary iron on intestinal inflammation. Gastroenterology. 2010; 138: S-580.
321. Werner T, Wagner SJ, Martinez I, et al. Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis. Gut. 2011; 60: 325-333.
322. Zimmermann MB, Chassard C, Rohner F, et al. The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d'Ivoire. Am J Clin Nutr. 2010; 92: 1406-1415.
323. Ettreiki C, Trakhna F, Gadonna-Widehem P, et al. P0165 Impact of iron on intestinal microbiota equilibrium, inflammtory and orientation of immune responses during IBD. Gut. 2010; 59: A139.